FDA Approves New Treatment for Thyroid Eye Disease

• by Kathryn Wighton

• June 29, 2026

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.

• by Andrea Surnit

• September 8, 2026

• 4 min

How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.

• by Andrea Surnit

• August 12, 2026

• 3 min

FDA expands essential thrombocythemia care

Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.

• by Kathryn Wighton

• September 1, 2026

• 2 min